Nationwide analysis of in-hospital mortality and renal infarction trends following cardiac output assist device placement from 2017 to 2020

30 August 2024 (08:00 - 17:30)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Adarsh Balaji

Brookdale University Hospital & Medical Center, Brooklyn (United States of America)

5 More presentations in this session

Presentation thumbnail

Beating the clock: the impact of heart failure duration on CRT efficacy

Mr E. Grama (Barcelona, ES)

Abstract Slides

Presentation thumbnail

Optimizing aldosterone receptor antagonist therapy by sodium zirconium cyclosilicate in heart failure - OPRA-HF trial

Doctor C. Basic (Gothenburg, SE)

Abstract Slides

Presentation thumbnail

Understanding the benefits of renin-angiotensin-aldosterone system inhibitors and influence of hyperkalaemia on their prescription: a UK survey of healthcare professionals' views and practice

Doctor M. Wasef (Portsmouth, GB)

Abstract Slides Video

Presentation thumbnail

Diuretic dosing and outcomes with torsemide and furosemide following hospitalization for heart failure: the TRANSFORM-HF trial

Miss N. Nouhravesh (Durham, US)

Abstract Slides

Presentation thumbnail

Echocardiographic evaluation of cardiac remodelling in a cohort of patients with heart failure and reduced ejection fraction treated with dapagliflozin

Doctor J. Bonini (Ferrara, IT)

Abstract Slides

Access the full session

Session thumbnail

Drugs, devices, and multidisciplinary care in heart failure

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

You may be interested in

Congress Session

Which device might help your HFpEF patient?

Congress Session

Navigating through heart failure device therapies

Congress Session

Devices in acute heart failure

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources